RYR2 and Ventricular arrhythmia: For example, the targeted silencing of the ryanodine receptor 2 (RYR2) gene mutation can reduce the expression level of the R4496C mutant RYR2 protein, increase the wild-type expression level, and reduce the incidence of ventricular arrhythmia induced by isoproterenol [8].